authors
- Saranya P. Wyles, MD, PhD
- Yamada, Satsuki
- Oommen, Saji
- Maleszewski, Joseph J
- Beraldi, Rosanna
- Martinez-Fernandez, Almudena
- Terzic, Andre
- Nelson, Timothy J
Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy.
- Overview
- Identity
- Additional Document Info
- View All